ArticleClinical and experimental medicine2026
Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.
Yue Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.